Supplement Article

Recently published article about Supplement Article

JCP
The GABA Pathway and New Clinical Trial Data in MDD and PPD
Supplement Article

March 16, 2023

Studies evaluating neuroactive steroid GABA-A receptor positive allosteric modulators demonstrate promising results for the treatment of MDD and PPD.
JCP
Supplement Article

October 26, 2018

Are you familiar with diagnostic criteria for Parkinson disease psychosis (PDP)? Do you know which psychotic symptoms occur in the majority of patients with PD? Read this CME supplement...
JCP
Supplement Article

January 25, 2017

JCP
Supplement Article

January 25, 2017

JCP
Supplement Article

January 25, 2017

JCP
Supplement Article

January 25, 2017

Recent JCP Articles on Supplement Article

JCP
Ketamine/Esketamine in Bipolar Depression in a Clinical Setting
Original Research

October 2, 2024

In a small sample of patients with bipolar depression treated with ketamine/esketamine, no evidence of mania or hypomania was seen during acute treatment.
JCP
Suicide Risk Evaluation and Advanced AI Models
Original Research

October 2, 2024

This study explored how ChatGPT-3.5 and ChatGPT-4 assess suicide risk factors like previous attempts, gender, and age, focusing on their predictions about different types of suicidal behavior.
JCP
Algorithms for TRD Treatment Success
Insights

September 27, 2024

Dr. Nolan Williams delves into the innovative Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for treating resistant depression. Explore groundbreaking research, clinical trials, and the transformative potential of personalized brain...

Recent PCC Articles on Supplement Article

PCC
Black Hairy Tongue: A Rare Adverse Effect of Olanzapine
Case Report

October 3, 2024

A young woman recently diagnosed with a manic episode developed black discoloration on the dorsum of her tongue 3 weeks after starting olanzapine.
PCC
Age-Friendly Health Systems
Case Report

October 3, 2024

The age-friendly health systems movement promotes 4 evidence-based geriatric care principles known as the “4Ms”: What Matters, Medications, Mobility, and Mentation. Read on to find out more.
PCC
Withdrawal Psychosis During a Digital Detoxification Camp
Case Report

October 1, 2024

A 24-year-old woman with a history of depression, anxiety, and ADHD presented with ongoing auditory and visual hallucinations and aggressive behavior that manifested while she was undergoing treatment at...

Featured Supplement Article Research

Anxiety Grips Voters as Election Day Looms
news

October 4, 2024

The upcoming election is putting a strain on the mental health of many Americans, particularly younger voters and women.
Weekly Mind Reader: The Digital Era’s Impact on Mental Health
news

October 4, 2024

This week covers mental health in the digital era, a ketamine update, and AI’s role in calculating suicide risk.
A Third of Former NFL Players Believe They Have CTE
news

October 3, 2024

One in three former NFL players believe they have CTE, raising concerns about the mental health toll of that belief.
JCP
Supplement Article

September 15, 2016

JCP
Supplement Article

September 15, 2016

JCP
Supplement Article

September 15, 2016

JCP
Supplement Article

September 15, 2016

JCP
Supplement Article

September 15, 2016

JCP
Supplement Article

February 24, 2016